Ofra Barchad-Avitzur

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Ofra Barchad-Avitzur is an author at Hebrew University of Jerusalem specializing in cystic fibrosis pharmacotherapy, molecular biology, and antisense rnas.

ORCID

Publications per year

2021–2023

Publications

Antisense oligonucleotide-based drug development for Cystic Fibrosis patients carrying the 3849+10 kb C-to-T splicing mutation

Yifat S. Oren, Michal Irony‐Tur Sinai, Anita Golec et al. · Journal of Cystic Fibrosis · 2021 · 52 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide Drug for 3849 + 10 kb C- > T Cystic Fibrosis Patients

E. Ozeri-Galai, Lital Friedman, Ofra Barchad-Avitzur et al. · Nucleic Acid Therapeutics · 2023 · 17 citations

Pharmacy, Molecular Biology, Pharmacology +17

1–2 of 2